With a strong scientific-stage pipeline, Agenus harnesses a combination of proprietary antibody platforms, which include Retrocyte Show™ and SECANT®, and impressive mobile therapy approaches, positioning itself for a critical contributor from the biotechnology and immunotherapy arena.Sustaining independence and editorial independence is crucial